| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Heritage Living Ctr is a Ashland, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthEd is a specialized agency that uses education to help people develop the knowledge, skills, motivation, and confidence to manage important health decisions and activities and ultimately achieve better health outcomes.
Valley Research is a South Bend, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symbion Research International, Inc is a Newbury Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.